Same Indication

Ipilimumab vs Technetium Tc 99M Sestamibi

Ipilimumab vs Technetium Tc 99M Sestamibi: Overview

This comparison examines the pharmacological differences between Ipilimumab and Technetium Tc 99M Sestamibi.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days.

Chemical Properties

Type: Ipilimumab β€” Antibody; Technetium Tc 99M Sestamibi β€” Small molecule.